Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Morning bid: Tariff medicine's crippling side effects
    Finance

    Morning bid: Tariff medicine's crippling side effects

    Published by Global Banking & Finance Review®

    Posted on April 7, 2025

    3 min read

    Last updated: January 24, 2026

    Morning bid: Tariff medicine's crippling side effects - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Quick Summary

    Trump's tariffs are causing global market turmoil, with Asian stocks plummeting and recession fears rising. The Fed may cut rates, while the EU and China consider responses.

    Tariff Medicine: The Economic Impact on Global Markets

    (Reuters) - A look at the day ahead in European and global markets from Wayne Cole

    Another day, another rout in Asian markets as President Trump shows no sign of backing away from his tariff plans despite the bonfire of wealth engulfing equity markets.

    Investors had thought the spectre of trillions of dollars lost would make Trump reconsider, or at least shake his aides, but he seems to feel this harsh medicine will help in the long run. Billionaire fund manager Bill Ackman, who endorsed Trump's run for President, seemed to think otherwise, saying the tariffs were an "economic nuclear winter" for the world.

    The chill was certainly felt in Asia where the Nikkei shed another 6% and Chinese blue chips almost 7%, despite talk that Beijing would come to the rescue with stimulus steps.

    Poor Taiwan returned from a break with losses of almost 10% as Trump's sky-high levies threaten the supply chains that so much of the world's business has come to rely on. Taiwan's policymakers acted to curb short selling and circuit breakers were tripped in a host of markets.

    Dealers were increasingly concerned the markets' losses would force investors to dump profitable assets just to cover their margin calls, leading to a self-fuelling fire sale.

    JPMorgan now sees a 60% chance of a U.S. recession and Fed rate cuts from June to next January, leaving the funds rate around 3%. Futures markets were also moving that way, with the December Fed funds contract up an astonishing 30 basis points at one stage this morning, before paring that back to 16 ticks.

    Markets even imply a 50-50 chance the Fed could ease as early as May, despite Chair Powell's reiteration last week that the central bank was in no hurry to move.

    His reticence is understandable given how tariffs are set to lift the price of everything from cars to food. It's likely too early for the U.S. March consumer price report this week to show the impact, but that won't last for long.

    Trump has said many countries were looking to do deals to ease the tariff pain. Problem is, the "reciprocal" U.S. rates chosen were much, much higher than the levies actually imposed by most other nations, making it hard for them to offer deals "beautiful" enough to satisfy Trump.

    China seems ready for the fight, in part because it sees a chance to become the trade partner you can trust, replacing the U.S. There could also be more hints of EU reprisals when the region's trade ministers meet later on Monday.

    All of this is happening just as the U.S. earnings season is due to start with major banks on Friday, and it will be a brave CEO who expresses anything but caution about the outlook for profits and sales.

    Key developments that could influence markets on Monday:

    - EU retail sales, Sentix investor confidence, German industrial output

    - Appearances by ECB board member Piero Cipollone and Fed Governor Kugler

    (By Wayne Cole; Editing by Edmund Klamann)

    Key Takeaways

    • •Trump's tariffs continue to unsettle global markets.
    • •Asian markets experience significant losses.
    • •JPMorgan predicts a 60% chance of US recession.
    • •Fed rate cuts anticipated amid economic strain.
    • •EU and China prepare responses to US tariffs.

    Frequently Asked Questions about Morning bid: Tariff medicine's crippling side effects

    1What is the main topic?

    The article discusses the impact of Trump's tariffs on global markets and the potential economic consequences.

    2How are Asian markets affected?

    Asian markets have experienced significant losses, with the Nikkei and Chinese blue chips dropping sharply.

    3What is the likelihood of a US recession?

    JPMorgan estimates a 60% chance of a US recession due to the economic impact of tariffs.

    More from Finance

    Explore more articles in the Finance category

    Image for The Kyiv family, with its pets and pigs, defying Russia and the cold
    The Kyiv family, with its pets and pigs, defying Russia and the cold
    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    View All Finance Posts
    Previous Finance PostFactbox-US companies most vulnerable to China's retaliatory import tariffs
    Next Finance PostExclusive-Iran-backed militias in Iraq ready to disarm to avert Trump wrath